SIB COV [COVID-19]

  • Research type

    Research Study

  • Full title

    Systems immunology and biochemistry of immune responses to SARS-CoV-2

  • IRAS ID

    288762

  • Contact name

    Deborah Dunn-Walters

  • Contact email

    d.dunn-walters@surrey.ac.uk

  • Sponsor organisation

    University of Surrey

  • Clinicaltrials.gov Identifier

    BB/T002212/1 , funders reference number; BB/V011456/1 , funders reference number

  • Duration of Study in the UK

    5 years, 0 months, 1 days

  • Research summary

    Understanding the immune and biochemical response to an infection is crucial to know how long immunity from infection will last and whether the correct types of immune response are being made in order to be protective (as opposed to being inflammatory and contributing to disease pathology, such as for SARS-CoV-2 and COVID-19 disease).
    Our aim is:
    Observational study to look at immune and biochemical markers in blood, sweat and saliva from COVID-19 patients at the time of illness and at follow up. Aiming to find biomarkers of disease severity and understand the immune protection versus immune pathology. This is a continuation of current work, longitudinal follow up is crucial to understand immunity. Additions to the protocol include consent procedures for patients lacking capacity. Also this work is now funded by BBSRC so we are asking for a new ethics with this in order to register the study on CRN.

  • REC name

    North West - Greater Manchester East Research Ethics Committee

  • REC reference

    20/NW/0453

  • Date of REC Opinion

    13 Jan 2021

  • REC opinion

    Further Information Favourable Opinion